VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
EVAXEvaxion Biotech A/S
$3.17$20M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksEVAXPrice History

EVAX logoEvaxion Biotech A/S (EVAX) Stock Price History

Historical prices from 2021 to 2026

$3.17-0.15  (-4.52%)close Jun 18
Returns
1M
-22.5%
3M
-16.1%
YTD
-32.7%
1Y
+46.1%
3Y
-63.2%
5Y
-60.6%
ATH$517.00Feb 2021-99.4%
ATL$1.20Apr 2025pre-split
Avg Vol (50D)31K/ day
52-Week Range$2.25 — $12.15
LowCurrent: $3.17High

Loading 10-year price history...

EVAX Historical Performance

1 YearTotal Return
+46.1%
Price: +46.1%
3 YearsTotal Return
-95.0%
CAGR: -63.2%
Price: -95.0%
5 YearsTotal Return
-99.1%
CAGR: -60.6%
Price: -99.1%
YTD
-32.7%

EVAX Annual Returns

Year-by-year price performance · 2021–2026

Best+3.2%2025
Worst-88.4%2024
Up years1/6
2021-55.3%
2022-61.2%
2023-60.6%
2024-88.4%
2025+3.2%
2026-32.9%
2021 annual price return
-55.3%
2022 annual price return
-61.2%
2023 annual price return
-60.6%
2024 annual price return
-88.4%
2025 annual price return
+3.2%
2026 annual price return
-32.9%
LessMore
Alpha vs S&P 500
1Y+21.1%
3Y-82.1%
5Y-72.7%

Price returns only.

Download Historical Data

1,349 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

EVAX Stock Price Trajectory (2021–2026)

As of June 22, 2026, Evaxion Biotech A/S (EVAX) trades at $3.17, representing a +46.1% return over the past year. The stock has delivered a -99.1% total return over five years (-60.6% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $517.00 on February 8, 2021. From this peak, EVAX has corrected -99.4%, currently trading 29% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers NEON (-94.2% 1Y), IMVT (+122.8% 1Y), and NKTR (+608.2% 1Y), EVAX has underperformed the peer group average. Compare EVAX vs NEON →

EVAX Historical Price Data · from 2021

Rows 1–50 of 1,349
Date Open High Low Close Volume Change %
2026-06-183.323.403.053.1742K-4.52%
2026-06-173.353.503.253.3231K-2.92%
2026-06-163.553.663.423.4233K-5.00%
2026-06-153.643.793.583.6029K-3.49%
2026-06-123.773.773.643.7357K+3.32%
2026-06-113.843.843.603.6116K-4.75%
2026-06-103.703.963.603.7925K+4.41%
2026-06-093.663.833.613.6328K-5.96%
2026-06-083.743.873.733.8619K+8.73%
2026-06-053.983.983.423.552K-8.27%
2026-06-043.503.993.503.8757K+9.32%
2026-06-033.753.753.523.5418K-5.60%
2026-06-023.873.873.703.7544K-3.85%
2026-06-013.853.923.853.9036K-2.50%
2026-05-294.054.144.004.0019K-2.44%
2026-05-284.124.154.084.109K+1.11%
2026-05-274.104.233.964.0585K-1.34%
2026-05-264.094.204.044.1118K+0.74%
2026-05-224.074.254.004.0825K+0.49%
2026-05-213.904.133.904.0623K+1.50%
2026-05-204.054.083.904.0014K+0.50%
2026-05-194.094.113.893.9811K-2.69%
2026-05-184.034.124.034.0929K+4.34%
2026-05-154.004.143.923.9226K-2.24%
2026-05-144.164.214.004.0155K-3.61%
2026-05-134.174.354.154.1627K-0.24%
2026-05-124.234.354.154.1729K-2.80%
2026-05-114.364.504.244.2941K-1.15%
2026-05-084.014.504.014.3437K+6.63%
2026-05-074.344.393.934.0738K-7.71%
2026-05-064.454.484.364.419K+0.23%
2026-05-054.614.684.404.4019K-3.72%
2026-05-044.524.744.434.5729K+1.67%
2026-05-014.414.604.314.5030K+1.93%
2026-04-304.244.454.204.4116K+6.27%
2026-04-294.354.374.154.157K-3.94%
2026-04-284.144.364.144.3233K+3.35%
2026-04-274.264.374.064.1837K+3.72%
2026-04-244.274.273.934.0331K-5.18%
2026-04-234.414.414.164.2540K-0.47%
2026-04-224.534.534.274.2731K-5.11%
2026-04-214.504.554.284.5029K-1.96%
2026-04-204.524.604.304.5960K+3.15%
2026-04-174.294.714.044.45113K+7.49%
2026-04-163.994.253.964.1434K0.00%
2026-04-154.084.143.974.1422K0.00%
2026-04-144.024.174.014.1414K0.00%
2026-04-134.064.144.044.1411K+2.48%
2026-04-104.094.223.884.0476K-1.70%
2026-04-094.134.504.004.1124K+1.23%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

EVAX — Frequently Asked Questions

Quick answers to the most common questions about buying EVAX stock.

How has EVAX stock performed recently?

EVAX returned +46.1% over the past year, beating its 5-year annualized CAGR of -60.6%. The stock trades below its 200-day moving average, confirming the uptrend.

What is EVAX's all-time high price?

Evaxion Biotech A/S reached $517.00 on 2021-02-08. The 52-week high is $12.15. Current 1-year return of +46.1% places the stock closer to historical peaks.

Where can I download EVAX historical price data?

This page provides EVAX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

451 data points · sampled from 1,349